Search results
Jun 10, 2024 · Goldenberg is the founder and president of the Center for Molecular Medicine and Immunology, now located in Mendham, New Jersey, funded by the National Cancer Institute. From 1983-2017, he was founder, chairman of the board, and chief scientist of Immunomedics, Inc., which developed antibody-based diagnostic imaging and therapeutic agents for cancer and certain autoimmune diseases.
Dr. Goldenberg is the inventor of over 200 scientific patents. He has published more than 900 peer-reviewed articles, and has edited two books and 14 journal supplements. He has collaborated and published with investigators at American universities and medical centers, and at international research centers including the Karolinska Institutet in ...
David M. Goldenberg, Sc.D., M.D., spent ~60 years in medical research, both clinical and nonclinical, in cancer research and autoimmune diseases. He served in professorial positions at five ...
Dr. David Goldenberg is a pioneer in monoclonal antibodies and immunotherapy. He received a degree from the University of Chicago College and Division of Biological Sciences in 1958, a Faculty of Natural Sciences degree (Sc.D.) from the University of Erlangen-Nuremberg in 1965, and his M.D. degree from the University of Heidelberg School of Medicine in 1966.
RFA patients return to the clinic that same week for a physical exam. Surveillance ultrasounds occur six and twelve months post-procedure. David counsels his patients that their nodule will not shrink immediately, and may swell in the days following their procedure. However, he expects the nodule to shrink 50-80% in the year following RFA.
Dr. Goldenberg has received national recognition, including Newsweek’s Top Cancer Doctors in the US, US News and World Report’s Top Doctors—Top 1% of Physicians in the nation, Best Doctors in America, and America’s Top Doctors for Cancer. Dr. Goldenberg combines a busy surgical practice with teaching and research.
People also ask
Who is John Goldenberg?
What is Dr. Goldenberg currently working on?
Who is David Goldenberg and what does he do?
Where does Mark Goldenberg currently live?
Where did Dr Goldenberg go to medical school?
How many articles has Dr Goldenberg published?
Targeted therapy of cancer: new prospects for antibodies and immunoconjugates. RM Sharkey, DM Goldenberg. CA: a cancer journal for clinicians 56 (4), 226-243. , 2006. 364. 2006. Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations.
